Interleukin 35 promotes progression of hepatocellular carcinoma by recruiting neutrophils

Background: A growing number of therapeutic strategies against hepatocellular carcinoma (HCC) have emerged. However, their efficacy remains limited. This study investigated the mechanism of interleukin-35 (IL-35) in the progression of HCC and its potential application in HCC treatment. Methods: The...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Wei Gan, Guo-Qiang Sun, Jin-Long Huang, Bao-Ye Sun, Zhu-Tao Wang, Zhang-Fu Yang, Cheng Zhou, Yong Yi, Shuang-Jian Qiu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2026-02-01
Serie:	Translational Oncology
Soggetti:	Hepatocellular carcinoma Interleukin 35 Immunotherapy Neutrophil Anti-PD1
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1936523325003614
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!